RBC Downgrades HOOKIPA Pharma to Sector Perform From Outperform, Slashes Price Target to $2 From $48, Keeps Speculative Risk
RBC Downgrades HOOKIPA Pharma to Sector Perform From Outperform, Slashes Price Target to $2 From $48, Keeps Speculative Risk
RBC將HOOKIPA Pharma評級從表現優於大盤下調至與大盤持平，目標價從48美元大幅削減至2美元，並保持投機風險。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間